Abbott Laboratories (NYSE: ABT), the broad-based health care company that produces both Humira and Similac, is scheduled to discuss its third quarter 2009 financial results in a conference call Wednesday at 9:00 AM ET. You can catch the live webcast on the company's website.

During the three months that ended in September, Abbott Labs announced acquisitions of Visiogen, Evalve, and Solvay pharmaceuticals, as well as declared its 343rd consecutive quarterly dividend. Analysts surveyed by Thomson Reuters expect this suburban Chicago company to report that earnings rose 12.2% from a year ago to $0.90 per share. Sales for the quarter are expected to be 3.3% higher to $7.8 billion.

Monday, April 14

• PDUFA date for Solvay S.A. (ADR) (OTC: SVYSY)'s standard supplemental New Drug Application, or sNDA, for AndroGel PD for the treatment of adolescent male Constitutional Delay in Growth and Puberty (CDGP); for which they are requesting pediatric exclusivity.
• Alpharma, Inc. (NYSE: ALO) to give 2008 financial outlook update at 8:30am.
• Eaton Corporation (ETN) to report Q1 earnings; conference call at 10:00am.

Tuesday, April 15

• PDUFA date for GlaxoSmithKline plc (ADR) (NYSE: GSK) and Pozen Inc. (NASDAQ: POZN)'s Trexinet, which has priority for 1st-line therapy for acute migraines.
• PDUFA date for Sciele Pharma Inc. (NASDAQ: SCRX) and Novo Nordisk A/S (ADR) (NYSE: NVO)'s PrandiMet for non-insulin dependent Diabetes Mellitus/Type 2 Diabetes treatment.
• Johnson & Johnson (NYSE: JNJ) to report Q1 earnings; conference call at 8:30am.
• Intel Corporation (NASDAQ: INTC) to report Q1 earnings; conference call at 5:30pm.

Wednesday, April 16

• San Francisco Fed Bank President Yellen to speak on the Economic Outlook in San Francisco at 11:45am.
• International Business Machines Corp. (NYSE: IBM) to report Q1 earnings; conference call at 4:30pm.
• eBay Inc. (NASDAQ: EBAY) to report Q1 earnings; conference call at 5:00pm.